Healthcare and Pharma Project Finance Above ₹10 Crore
Structured Term Loans • Banking Consortium Syndication • Equipment Capex • Working Capital
CreditCares syndicates and structures customized project loans from ₹10 Crore to ₹100+ Crore for hospitals, diagnostic chains, formulation units, and API plants across India. Facilities feature 65% to 75% debt coverage, competitive 8.65% to 10.75% interest rates, up to 15-year amortizations, and 12 to 36-month construction moratoria.
Submit Loan Requirement (> ₹10 Cr)
Fast-track review by our credit syndication desk in Mumbai & Kolkata.
Hospital & Healthcare Infrastructure
Structured term loans for greenfield hospital construction, 50 to 300 bed additions, high-end diagnostic suites (3T MRI, 128 Slice CT, Cath Lab), oncology centers, and operational hospital acquisitions.
Pharmaceutical Manufacturing & API Capex
Project debt for WHO-GMP and USFDA-compliant formulation plants, active pharmaceutical ingredient (API) chemical synthesis blocks, cleanrooms, lyophilizers, and large-scale CC/OD export credit limits.
Loan Eligibility & Project Bankability Checker
Input your annual turnover, existing debt, and project location to calculate an instant institutional Project Bankability Score across ₹10 Cr to ₹150+ Cr facilities.
Your leverage and revenue scale provide robust debt-servicing headroom. Commercial bank credit committees typically fast-track proposals with this profile with competitive pricing.
Direct access to National Credit Committees at BKC and lower administrative processing delays.
Hospital & Pharma DSCR Cash Flow Calculator
Model Debt Service Coverage Ratio (DSCR), interest during construction, and promoter equity allocation across ₹10 Cr to ₹150+ Cr capex facilities.
Comfortable headroom for PSU/Private Bank Consortium sanction. Minimum institutional PSU threshold is 1.25x; top private healthcare desks require 1.35x.
Project Cost & Means of Finance Builder
Break down civil construction, medical/pharma equipment, and interest during construction (IDC) to evaluate the 70:30 debt-to-equity envelope.
Closed Deals & Syndication Tombstones (> ₹10 Cr)
Real institutional debt closures above ₹10 Crore across hospitals, oncology centers, USFDA API synthesis units, and formulation plants across India.
₹42.00 Cr Multi-Specialty Hospital Greenfield
220-bed tertiary care hospital project in Mumbai MMR comprising 5 modular OTs, 30 ICU beds, and 1.5T MRI suite.
₹68.00 Cr USFDA-Compliant API Synthesis Facility
Greenfield bulk drug manufacturing plant with multi-purpose glass-lined reactors, hydrogenation unit, and zero-liquid discharge effluent plant.
₹32.00 Cr Sterile Injectables & Lyophilizer Unit
Upgradation to WHO-GMP sterile injectable vial facility with automated filling lines and cleanroom HVAC integration.
₹24.00 Cr Radiation Oncology & PET-CT Suite
Varian TrueBeam Linear Accelerator and Siemens Biograph PET-CT installation for premier cancer care institute.
₹18.00 Cr Pathology & Diagnostic Chain Expansion
Rollout of 24 diagnostic and collection hubs across Delhi NCR equipped with automated biochemistry and molecular testing analyzers.
₹54.00 Cr Brownfield Bed Expansion (180 to 350 Beds)
Consolidation of 3 high-cost facilities into a unified low-cost term loan while funding construction of a new 8-story super-specialty wing.
₹38.00 Cr CDMO Formulation Facility Expansion
Dedicated contract development and manufacturing block for European generic formulation supplies.
₹15.00 Cr Orthopedic & Robotic Joint Surgery Center
Procurement of Mako robotic joint surgery system and renovation of 60-bed specialized orthopedic facility.
Client Success Stories & Project Endorsements
Real financing outcomes achieved for hospital promoters, pharma manufacturers, and diagnostic chains across India. All borrower identities and corporate names are anonymized in compliance with strict banking non-disclosure agreements (NDAs).
"Our greenfield hospital project was stuck for nearly four months because standard bank branches were unable to evaluate the 18-month occupancy ramp-up curve. CreditCares completely re-engineered our Detailed Project Report (DPR), quantified our ARPOB model, and syndicated a ₹42 Cr consortium facility with an 18-month principal moratorium that protected our working capital until break-even."
"Setting up a sterile injectable line with cleanroom HVAC and a freeze dryer lyophilizer requires substantial pre-operative capital during validation batch audits. CreditCares structured a synchronized ₹32 Cr term loan alongside a ₹10 Cr working capital line, while also advising us on availing the 6% interest subvention under the Gujarat Industrial Policy. Their knowledge of pharma engineering and banking covenants is unmatched."
"Syndicating ₹68 Crore for a chemical bulk drug plant in Genome Valley requires addressing strict zero-liquid discharge (ZLD) effluent standards and volatile raw material pricing. CreditCares built a defensible sensitivity model that proved our DSCR even under a 15% intermediate cost spike. They represented our file directly before the National Credit Committee in Mumbai and closed the sanction within 48 days."
"Procuring a TrueBeam Linear Accelerator and Siemens PET-CT scanner involved complex CIF import contracts and AERB room approvals. CreditCares structured an 85% equipment lease facility with a 6-month installation moratorium, meaning our monthly EMI only started after the radiotherapy machines were treating regular patients. The transaction concluded in just 26 business days."
"We were previously servicing three disparate high-cost loans averaging 12.5% that were draining our clinical operating cash flow. CreditCares structured an institutional takeover, consolidating our debt at 9.15% while raising an additional ₹30 Cr for constructing our new 8-story cardiac and neurology wing. This single advisory exercise saved us over ₹1.8 Crore annually in interest servicing."
"Expanding a diagnostic network across Delhi NCR required a multi-tranche facility where we could draw down funds as each collection hub and automated analyzer arrived. CreditCares created an umbrella credit sanction of ₹18 Cr, allowing us to roll out 24 centers sequentially without paying commitment charges on unutilized tranches."
"We engaged CreditCares at their Mumbai Raheja Titanium office after our greenfield project was stalled by standard retail banking desks unable to evaluate hospital ramp-up economics. Their project finance team restructured our DPR, modeled an institutional 18-month principal moratorium, and represented our file directly before the lead PSU bank national credit committee. The ₹42 Cr facility was sanctioned and documented in 52 days."
"Setting up a sterile vial injectable plant requires synchronizing equipment imports (lyophilizer and automated vial filling) with state policy incentives. CreditCares not only secured our ₹32 Cr term loan with a 15-month validation moratorium but also guided our team through claiming the 6% interest subvention under the Gujarat Industrial Policy. Their technical and financial depth is far ahead of generic brokers."
"The CreditCares team at Godrej Waterside in Kolkata handled our oncology diagnostic expansion seamlessly. Importing a Varian TrueBeam linear accelerator and PET-CT involves complex CIF vendor contracts and AERB room clearances. They structured an 85% equipment lease with a 6-month commissioning moratorium without demanding real estate collateral outside the machines."
"For a ₹68 Cr API bulk drug plant in Genome Valley, underwriters scrutinized effluent treatment compliance and raw material pricing sensitivity. CreditCares built a defensible cash flow sensitivity model and negotiated a Common Loan Agreement across two nationalized banks within 48 days. Transparent advisory with zero hidden charges."
"We had three separate high-cost loans that were restricting our hospital operating cash flow. CreditCares took over our entire debt portfolio into a single low-cost 12-year bank term facility at 9.15% while raising ₹30 Cr fresh expansion funding for our new cardiac and neurology tower. We saved over ₹1.8 Crore annually in interest alone."
"Rolling out 24 diagnostic hubs across Delhi NCR required drawn-down flexibility as each center was ready for analyzer installation. CreditCares structured an umbrella facility with tranche drawdowns, shielding us from paying commitment penalties on undisbursed funds. Highly professional credit advisory firm."
Dual Registered Headquarters & Serviced Regional Hubs
Registered office in Mumbai (BKC) and corporate office in Kolkata (Salt Lake Sector V), with localized credit syndication desks in 18 primary healthcare and pharmaceutical industrial corridors.
Mumbai Headquarters
Raheja Titanium, Western Express Highway (Western Urban Rd), Goregaon East, Mumbai - 400063, Maharashtra
Kolkata Headquarters
Godrej Waterside, Tower II, DP Block, Salt Lake Sector V, Kolkata - 700091, West Bengal
Mumbai
MaharashtraRegistered OfficeRaheja Titanium, Western Express Highway (Western Urban Rd), Goregaon East, Mumbai - 400063
Western Urban Corridor, BKC, Andheri MIDC, Thane-Belapur Industrial Belt, Navi Mumbai Health Hubs
Multi-specialty Super Hospitals, Quaternary Care Centers, Large Pharma Corporate Debt
₹25 Cr to ₹150+ Cr
45 - 60 Days (Direct access to PSU & Private Bank National Credit Committees in BKC)
High FSI for medical zones, direct access to institutional consortium desks and mezzanine funds.
Institutional Debt Structuring FAQ
Direct, transparent answers regarding documentation dossiers, MCLR interest benchmarks, credit committee processing timelines, and consortium terms for mandates above ₹10 Crore.
Sector Insights & Project Finance Trends
In-depth research on Central Pharma PLI schemes, hospital DSCR financial modeling, AERB radiation compliances, and large-ticket debt syndication strategies.
Navigating the Production-Linked Incentive (PLI) for Bulk Drugs: Bankable Capex Structuring
How active pharmaceutical ingredient (API) manufacturers can align mandatory greenfield thresholds under the Central PLI scheme with institutional 70:30 bank debt syndication and state interest subventions.
Hospital Debt Service Coverage Ratio (DSCR): Modeling the 24-Month Bed Occupancy Ramp-Up
Why generic corporate DSCR models fail in hospital credit appraisals, and how to structure bankable cash flow models factoring in ARPOB, bed ramp-up curves, and medical equipment lease amortization.
Statutory Clearances in Hospital Capex: Preventing Costly Disbursement Tranche Freezes
A practical guide to securing Atomic Energy Regulatory Board (AERB) and State Pollution Control Board (SPCB) clearances in proper sequencing to ensure uninterrupted bank term loan tranches.
Consortium Debt Takeovers: Migrating High-Cost NBFC Debt to 12-Year Bank Term Facilities
How operating hospital networks and pharma manufacturing units can restructure high-cost mezzanine or interim debt down to 8.75% bank term loans with extended 12 to 15-year tenures.
Is Your Hospital or Pharma Project Dossier Bankable?
Over 70% of large-ticket healthcare and pharma applications face months of delay due to incomplete civil architect estimates or pending SPCB/AERB clearances. Evaluate your dossier against our 28-point institutional benchmark.